Answers are grounded in this paper and cite their sources.
Depression is a chronic disease seen in many healthcare settings. Current pharmacological treatment options are successful in two-thirds of patients. One CYP450 enzyme, CYP2D6, is responsible for the metabolism of 30% of all drugs including many antidepressants. Phenotypes of metabolizer status affect antidepressant treatment outcomes and adverse drug reactions.
No takes yet. Share an insight, caveat, or question.
Krauter et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: